3OW3 image
Entry Detail
PDB ID:
3OW3
Title:
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2010-09-17
Release Date:
2010-11-10
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:cAMP-dependent protein kinase catalytic subunit alpha
Chain IDs:A
Chain Length:350
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:cAMP-dependent protein kinase inhibitor alpha
Chain IDs:B
Chain Length:20
Number of Molecules:1
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER PHOSPHOSERINE
TPO A THR PHOSPHOTHREONINE
Ligand Molecules
Primary Citation
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors.
Bioorg.Med.Chem.Lett. 20 7037 7041 (2010)
PMID: 20971641 DOI: 10.1016/j.bmcl.2010.09.112

Abstact

Herein we report the discovery and synthesis of a novel series of dihydrothieno- and dihydrofuropyrimidines (2 and 3) as potent pan Akt inhibitors. Utilizing previous SAR and analysis of the amino acid sequences in the binding site we have designed inhibitors displaying increased PKA and general kinase selectivity with improved tolerability compared to the progenitor pyrrolopyrimidine (1). A representative dihydrothieno compound (34) was advanced into a PC3-NCI prostate mouse tumor model in which it demonstrated a dose-dependent reduction in tumor growth and stasis when dosed orally daily at 200 mg/kg.

Legend

Protein

Chemical

Disease

Primary Citation of related structures